We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Globalstar
GSAT
$10.1B
| $10.2M | 0.14% |
246,829
+15,697
| +7% | +$602K |
|
127
PUT
T-Mobile US
TMUS
$195B
| $10.2M | 0.14% |
376,800
+373,097
| +10,076% | +$10.3M |
|
|
FOE
128
DELISTED
Ferro Corporation
FOE
| $10.1M | 0.14% |
775,907
+145,405
| +23% | +$1.91M |
|
|
GG
129
DELISTED
Goldcorp Inc
GG
| $9.96M | 0.14% |
537,852
+526,752
| +4,746% | +$10.8M |
|
|
SNR
130
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
| $9.82M | 0.14% |
+596,548
| New | +$10.3M |
|
131
KeyCorp
KEY
$23.8B
| $9.71M | 0.14% |
698,512
+59,799
| +9% | +$795K |
|
132
Huntsman Corp
HUN
$2.1B
| $9.58M | 0.14% |
420,453
+291,776
| +227% | +$7.08M |
|
133
PUT
Lumen
LUMN
$6.43B
| $9.5M | 0.13% |
240,000
+238,400
| +14,900% | +$9.54M |
|
134
Lincoln National
LNC
$7.92B
| $9.49M | 0.13% |
+164,617
| New | +$8.96M |
|
135
PUT
iShares Russell 2000 ETF
IWM
$79.1B
| $9.49M | 0.13% |
79,300
+77,550
| +4,431% | +$8.87M |
|
136
Willis Towers Watson
WTW
$29.8B
| $9.45M | 0.13% |
79,582
-17,309
| -18% | -$1.94M |
|
137
ATI
ATI
$24.3B
| $9.41M | 0.13% |
+270,514
| New | +$8.94M |
|
|
MNTA
138
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $9.39M | 0.13% |
780,149
+438,149
| +128% | +$5.01M |
|
139
Aptiv
APTV
$12.3B
| $9.34M | 0.13% |
128,369
+44,474
| +53% | +$3.07M |
|
140
CALL
Madison Square Garden
MSGS
$9.59B
| $9.23M | 0.13% |
+171,885
| New | +$8.66M |
|
141
Sensata Technologies
ST
$6.69B
| $9.11M | 0.13% |
173,841
-53,520
| -24% | -$2.6M |
|
|
APC
142
DELISTED
Anadarko Petroleum
APC
| $9.01M | 0.13% |
109,238
-70,693
| -39% | -$6.16M |
|
|
RFMD
143
DELISTED
RF MICRO DEVICES INC
RFMD
| $8.96M | 0.13% |
539,795
-508,755
| -49% | -$6.79M |
|
144
Encompass Health
EHC
$11.3B
| $8.91M | 0.13% |
291,133
-5,322
| -2% | -$166K |
|
145
Xenon Pharmaceuticals
XENE
$6.1B
| $8.89M | 0.13% |
+450,000
| New | +$6.61M |
|
146
PUT
Restaurant Brands International
QSR
$26.2B
| $8.84M | 0.12% |
+226,500
| New | +$8.7M |
|
|
FLNA
147
Filana Therapeutics
FLNA
$42M
| $8.83M | 0.12% |
621,436
-7
| -0% | -$121 |
|
|
NRX
148
DELISTED
NEPHROGENEX INC COM
NRX
| $8.8M | 0.12% |
658,969
+181,969
| +38% | +$843K |
|
|
SFLY
149
DELISTED
Shutterfly, Inc.
SFLY
| $8.77M | 0.12% |
210,398
+41,551
| +25% | +$1.77M |
|
|
NBSE
150
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $8.62M | 0.12% |
2,584
-375
| -13% | -$1.15M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.